blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2322158

EP2322158 - RESVERATROL AND/OR GRAPE LEAF EXTRACT FOR ENERGY METABOLISM ACTIVATION [Right-click to bookmark this link]
Former [2011/20]Resveratrol and/or grape leaf extract for energy metabolism activation
[2011/36]
StatusNo opposition filed within time limit
Status updated on  16.04.2021
Database last updated on 11.01.2025
FormerThe patent has been granted
Status updated on  08.05.2020
FormerGrant of patent is intended
Status updated on  16.01.2020
FormerExamination is in progress
Status updated on  04.11.2016
Most recent event   Tooltip24.06.2022Lapse of the patent in a contracting state
New state(s): CY, HU		published on 27.07.2022  [2022/30]
Applicant(s)For all designated states
KAO CORPORATION
14-10, Nihonbashi-Kayabacho 1-chome Chuo-ku
Tokyo 103-8210 / JP
[2011/20]
Inventor(s)01 / Minegishi, Yoshihiko
c/o Kao Corporation Research Laboratories
2606 Akabane
Ichikai-machi, Haga-gun
Tochigi 321-3497 / JP
02 / Murase, Takatoshi
c/o Kao Corporation Research Laboratories
2606 Akabane
Ichikai-machi, Haga-gun
Tochigi 321-3497 / JP
03 / Haramizu, Satoshi
c/o Kao Corporation Research Laboratories
2606 Akabane
Ichikai-machi, Haga-gun
Tochigi 321-3497 / JP
 [2020/24]
Former [2011/20]01 / Minegishi, Yoshihiko
c/o Kao Corporation Research Laboratories 2606 Akabane Ichikai-machi, Haga-gun
Tochigi 321-3497 / JP
02 / Murase, Takatoshi
c/o Kao Corporation Research Laboratories 2606 Akabane Ichikai-machi, Haga-gun
Tochigi 321-3497 / JP
03 / Haramizu, Satoshi
c/o Kao Corporation Research Laboratories 2606 Akabane Ichikai-machi, Haga-gun
Tochigi 321-3497 / JP
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2020/24]
Former [2011/20]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastraße 4
81925 München / DE
Application number, filing date11150018.725.10.2006
[2011/20]
Priority number, dateJP2005031150426.10.2005         Original published format: JP 2005311504
[2011/20]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2322158
Date:18.05.2011
Language:EN
[2011/20]
Type: A3 Search report 
No.:EP2322158
Date:28.09.2011
Language:EN
[2011/39]
Type: B1 Patent specification 
No.:EP2322158
Date:10.06.2020
Language:EN
[2020/24]
Search report(s)(Supplementary) European search report - dispatched on:EP31.08.2011
ClassificationIPC:A23L2/52, A23L33/105, A61K36/87, A61K31/05, A61K47/22, A61K9/00, A61K9/20, A61K9/48
[2020/02]
CPC:
A61K9/4858 (EP,US); A23L2/52 (EP,US); A23L33/105 (EP,US);
A61K31/05 (EP,US); A61K36/87 (EP,US); A61K47/22 (EP,US);
A61K9/0095 (EP,US); A61K9/2018 (EP,US); A61K9/4866 (EP,US);
A61P3/00 (EP); A61P43/00 (EP); A23V2002/00 (EP,US) (-)
C-Set:
A61K31/05, A61K2300/00 (EP,US);
A61K36/87, A61K2300/00 (US,EP);
A23V2002/00, A23V2200/302, A23V2250/21, A23V2250/21166 (US,EP);
A23V2002/00, A23V2200/316, A23V2250/21, A23V2250/21166 (US,EP);
A23V2002/00, A23V2200/33, A23V2250/21, A23V2250/21166 (EP,US)
(-)
Former IPC [2013/41]A23L1/30, A23L2/52, A61K36/87, A61K31/05, A61K47/22, A61K9/00, A61K9/20, A61K9/48
Former IPC [2011/20]A61K31/05, A61K36/87, A61P3/00, A61P43/00, A61K9/10, A61K9/16, A61K9/20, A61K9/48
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2020/24]
Former [2011/20]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:RESVERATROL UND/ODER TRAUBENBLATTEXTRAKT ZUR AKTIVIERUNG DES ENERGIEMETABOLISMUS[2011/36]
English:RESVERATROL AND/OR GRAPE LEAF EXTRACT FOR ENERGY METABOLISM ACTIVATION[2011/36]
French:RESVERATROL ET/OU EXTRAIT DE GRAPPES POUR ACTIVIER LE METABOLISME ENERGETIQUE[2011/36]
Former [2011/20]Resveratrol und/oder Traubenblattextrakt zur Aktivierung des Energiemetabolismus
Former [2011/20]Resveratrol and/or grape leaf extract for energy metabolism activation
Former [2011/20]Resveratrol et/ou extrait de grappes pour activer le métabolisme énergétique
Examination procedure03.01.2011Examination requested  [2011/20]
28.03.2012Amendment by applicant (claims and/or description)
04.11.2016Despatch of a communication from the examining division (Time limit: M06)
03.05.2017Reply to a communication from the examining division
24.11.2017Despatch of a communication from the examining division (Time limit: M01)
08.12.2017Reply to a communication from the examining division
17.01.2020Communication of intention to grant the patent
28.04.2020Fee for grant paid
28.04.2020Fee for publishing/printing paid
28.04.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP06822740.4  / EP1993522
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20060822740) is  12.01.2010
Opposition(s)11.03.2021No opposition filed within time limit [2021/20]
Fees paidRenewal fee
03.01.2011Renewal fee patent year 03
03.01.2011Renewal fee patent year 04
03.01.2011Renewal fee patent year 05
25.10.2011Renewal fee patent year 06
18.10.2012Renewal fee patent year 07
24.10.2013Renewal fee patent year 08
28.10.2014Renewal fee patent year 09
26.10.2015Renewal fee patent year 10
27.10.2016Renewal fee patent year 11
24.10.2017Renewal fee patent year 12
26.10.2018Renewal fee patent year 13
16.10.2019Renewal fee patent year 14
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU25.10.2006
AT10.06.2020
CY10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
ES10.06.2020
FI10.06.2020
IT10.06.2020
LT10.06.2020
LV10.06.2020
MC10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
SE10.06.2020
SI10.06.2020
SK10.06.2020
TR10.06.2020
BG10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
IE25.10.2020
LU25.10.2020
BE31.10.2020
CH31.10.2020
LI31.10.2020
[2022/27]
Former [2022/26]AT10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
ES10.06.2020
FI10.06.2020
IT10.06.2020
LT10.06.2020
LV10.06.2020
MC10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
SE10.06.2020
SI10.06.2020
SK10.06.2020
TR10.06.2020
BG10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
IE25.10.2020
LU25.10.2020
BE31.10.2020
CH31.10.2020
LI31.10.2020
Former [2021/46]AT10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
ES10.06.2020
FI10.06.2020
IT10.06.2020
LT10.06.2020
LV10.06.2020
MC10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
SE10.06.2020
SI10.06.2020
SK10.06.2020
BG10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
IE25.10.2020
LU25.10.2020
BE31.10.2020
CH31.10.2020
LI31.10.2020
Former [2021/37]AT10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
ES10.06.2020
FI10.06.2020
IT10.06.2020
LT10.06.2020
LV10.06.2020
MC10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
SE10.06.2020
SI10.06.2020
SK10.06.2020
BG10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
LU25.10.2020
BE31.10.2020
CH31.10.2020
LI31.10.2020
Former [2021/36]AT10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
ES10.06.2020
FI10.06.2020
IT10.06.2020
LT10.06.2020
LV10.06.2020
MC10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
SE10.06.2020
SI10.06.2020
SK10.06.2020
BG10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
LU25.10.2020
BE31.10.2020
Former [2021/31]AT10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
ES10.06.2020
FI10.06.2020
IT10.06.2020
LT10.06.2020
LV10.06.2020
MC10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
SE10.06.2020
SI10.06.2020
SK10.06.2020
BG10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
LU25.10.2020
Former [2021/24]AT10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
ES10.06.2020
FI10.06.2020
IT10.06.2020
LT10.06.2020
LV10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
SE10.06.2020
SI10.06.2020
SK10.06.2020
BG10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
Former [2021/20]AT10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
ES10.06.2020
FI10.06.2020
IT10.06.2020
LT10.06.2020
LV10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
SE10.06.2020
SK10.06.2020
BG10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
Former [2021/10]AT10.06.2020
CZ10.06.2020
EE10.06.2020
ES10.06.2020
FI10.06.2020
IT10.06.2020
LT10.06.2020
LV10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
SE10.06.2020
SK10.06.2020
BG10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
Former [2021/09]AT10.06.2020
CZ10.06.2020
EE10.06.2020
ES10.06.2020
FI10.06.2020
IT10.06.2020
LT10.06.2020
LV10.06.2020
NL10.06.2020
RO10.06.2020
SE10.06.2020
BG10.09.2020
GR11.09.2020
PT12.10.2020
Former [2021/04]FI10.06.2020
LT10.06.2020
LV10.06.2020
NL10.06.2020
SE10.06.2020
BG10.09.2020
GR11.09.2020
Former [2021/01]FI10.06.2020
LT10.06.2020
LV10.06.2020
SE10.06.2020
BG10.09.2020
GR11.09.2020
Former [2020/50]FI10.06.2020
LT10.06.2020
LV10.06.2020
SE10.06.2020
GR11.09.2020
Former [2020/48]FI10.06.2020
LT10.06.2020
SE10.06.2020
Former [2020/47]LT10.06.2020
Documents cited:Search[X]WO2005028464  (KAO CORP [JP], et al) [X] 2,3 * abstract *;
 [X]  - YANG YING-BAO ET AL, "Effects of resveratrol on secondary damages after acute spinal cord injury in rats.", ACTA PHARMACOLOGICA SINICA, (200307), vol. 24, no. 7, ISSN 1671-4083, pages 703 - 710, XP009077328 [X] 1,4 * page 707, columns R-H, paragraph 2 - page 709, columns L-H, paragraph 1 * * page 709, columns R-H, paragraph L *
 [XI]  - SINGH AMANPREET ET AL, "Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome.", JOURNAL OF MEDICINAL FOOD, (200201), vol. 5, no. 4, ISSN 1096-620X, pages 211 - 220, XP002654505 [X] 3 * abstract * * page 212, columns l-h, paragraph l * * Experimental procedure; page 212 * * page 215, columns l-h, paragraph 2; figure 1B * [I] 2

DOI:   http://dx.doi.org/10.1089/109662002763003366
 [X]  - LOGAN A C ET AL, "Chronic fatigue syndrome: oxidative stress and dietary modifications", ALTERNATIVE MEDICINE REVIEW, THORNE RESEARCH INC., SANDPOINT, US, (20011001), vol. 6, no. 5, ISSN 1089-5159, pages 450 - 459, XP009150507 [X] 3 * abstract *
ExaminationWO0021526
 WO2005069998
 WO2007008548
by applicantJPH05123135
 JPH0847381
 JPH1017585
 JP2001072853
 JP2001089387
 JP2002527389
 JP2002338464
 JP2003511476
 JP2004059518
 JP2005089384
 JP2005097161
 JP2005097162
 JP2005097273
 JP2005334022
 WO2005123058
 JP2006016409
 JP2006516542
    - SCIENCE, (1998), vol. 275, no. 5297, pages 218 - 220
    - CARDIOVASC. DRUG REV., (2004), vol. 22, no. 3, pages 169 - 188
    - NATURE, (2003), vol. 425, no. 6954, pages 191 - I96
    - AM. J. PHYSIOL. REGUL. INTEGR. CAMP. PHYSIOL., (2005), vol. 288, pages 708 - 715
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.